Background: Gestational diabetes mellitus (GDM), GDM is the first time of gestational impaired glucose tolerance in pregnant women. It is the most common complication disease in women of childbearing age. It is associated with the high risk of adverse health outcomes for both mothers and offsprings and the variety of metabolic disease, including type 2 diabetes, etc. As for the epidemiology data of GDM in China, the prevalence is around 18% based on the criteria from the International Association of Diabetes in Pregnancy Study Groups, IADPSG. Several studies claimed that the diabetes-specific formula improved glycemic control in type 2 diabetes patients. However, the effects of medical nutrition therapy combined with the diabetes-specific formula in pregnant women with gestational diabetes mellitus (GDM) are unclear. Objective: This study examines whether medical nutrition therapy combined with Enteral Nutrition Suspension (TFP-DM, Diason 0.75 kcal/ml) in GDM women could improve the glycemic control and the pregnancy outcomes.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in HbA1c from Baseline at 2 months
Timeframe: Gestational age 24-28 weeks and 32-34 weeks and 36-40 weeks and 42-70 days after delivery
Insulin treatmeant ratio
Timeframe: From enrollment to delivery
Change in serum glycated albumin from Baseline at 2 months
Timeframe: Gestational age 24-28weeks and 32-34weeks and 36-40 weeks and 42-70days after delivery
Change in fasting blood glucose concentration from Baseline at 2 months
Timeframe: Gestational age 24-28 weeks and 32-34 weeks and 36-40 weeks and 42-70 days after delivery
Change in Fasting insulin concentration from Baseline at 2 months
Timeframe: Gestational age 24-28 weeks and 32-34 weeks and 36-40 weeks and 42-70 days after delivery